Login

Gland Pharma Ltd.

₹1403.5

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Gland Pharma Ltd.

₹1403.5

₹1403.5

3.5 (0.25%) - 3 May 2025 04:30 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹23,124 Cr.
52 Week - High/Low ₹2,221/1,278
P/E Ratio 20.62
P/B Ratio 2.57
Enterprise Value ₹21,657 Cr.
ROE % 12.31
RSI Value 77.05
EMA 50 1512.48
EMA 200 1655.01
Net Profit 1,043 Cr.
Net Profit 3year growth 4.65 Cr.
Net Profit 3 year (back) 997 Cr.
Debt to Equity 0.0 %
EPS Growth TTM -23.38 %
Current Ratio 11.04 %
100 Day SMA 1,602 Rs.
200 Day SMA 1,723 Rs.
21 Day SMA 1,457 Rs.
50 Day SMA 1,520 Rs.
Book Value 546 Rs.
EV/EBITDA Ratio 13
QoQ EPS Growth 5 %
QoQ Operating Profit Growth 8 %
QoQ Sales Growth -5 %
Sales Latest Quarter 1,011 Cr.
YoY Sales Growth -8 %
Market Cap. ₹23,124 Cr.
52 Week - High/Low ₹2,221/1,278
P/E Ratio 32.82
P/B Ratio 2.65
Enterprise Value ₹21,773 Cr.
ROE % 9.26
RSI Value 77.05
EMA 50 1512.48
EMA 200 1655.01
Net Profit 772 Cr.
Net Profit 3year growth -3.03 Cr.
Net Profit 3 year (back) 997 Cr.
Debt to Equity 0.04 %
EPS Growth TTM 6.9 %
Current Ratio 4.04 %
100 Day SMA 1,602 Rs.
200 Day SMA 1,723 Rs.
21 Day SMA 1,457 Rs.
50 Day SMA 1,520 Rs.
Book Value 530 Rs.
EV/EBITDA Ratio 15
QoQ EPS Growth 25 %
QoQ Operating Profit Growth 21 %
QoQ Sales Growth -2 %
Sales Latest Quarter 1,384 Cr.
YoY Sales Growth -10 %
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.